Afdhal N H, Long A, Tobbia I, Cullen A, O'Donoghue D P
Gut. 1987 May;28(5):594-600. doi: 10.1136/gut.28.5.594.
A prospective study was undertaken to examine the immunohistochemical expression of tumor antigen Cal9-9 in 56 colorectal cancers and 95 colonic adenomas, divided into 65 primary polyps and 30 polyps synchronous with colorectal cancer. Seventy five per cent of tumours were positive for Cal9-9. Antigen was expressed more frequently in advanced Duke's C and D and poorly differentiated colorectal cancer. Overall 51% of adenomas were positive for Cal9-9. Antigen expression correlated significantly with increasing size (p less than 0.001), synchronicity with colorectal cancer (p less than 0.001), severe dysplasia (p less than 0.001) and villous typing (p less than 0.003). Discriminate analysis using the first three variables correctly classified 79% of positive and 89% of negative Cal9-9 results. The similar frequency of antigen expression seen in colorectal cancers and their synchronous adenoma suggests a field change in the tumour bearing colon. Adenomas positive for Cal9-9 may have a greater malignant potential for carcinomatous change.
开展了一项前瞻性研究,以检测肿瘤抗原Cal9-9在56例结直肠癌和95例结肠腺瘤中的免疫组化表达,结肠腺瘤分为65例原发性息肉和30例与结直肠癌同步的息肉。75%的肿瘤Cal9-9呈阳性。抗原在进展期杜克C期和D期以及低分化结直肠癌中更频繁表达。总体而言,51%的腺瘤Cal9-9呈阳性。抗原表达与肿瘤大小增加(p<0.001)、与结直肠癌同步(p<0.001)、重度发育异常(p<0.001)以及绒毛状分型(p<0.003)显著相关。使用前三个变量进行判别分析,正确分类了79%的Cal9-9阳性结果和89%的阴性结果。在结直肠癌及其同步腺瘤中观察到的相似抗原表达频率表明,携带肿瘤的结肠存在场效应改变。Cal9-9阳性的腺瘤发生癌变的恶性潜能可能更大。